Clinical Trials Browser

Phase 2 × INDUSTRY × Jacobs syndrome × Clear all

NCT00102726 2017-03-23

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

Phase 2 Completed

Classical hematology

Jacobs syndrome, Thrombocytopenia